ROSARIO ALFARO: Open Payments
NPI 1053686931 · NORTHFIELD, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$703 in 38 payments from 17 companies in 2025. Trend: 2023 $133 · 2024 $1,226 · 2025 $703
Food & beverage: $703
| Company | Payments | Amount |
|---|---|---|
| Bayer Healthcare Pharmaceuticals Inc. | 6 | $127 |
| SANOFI-AVENTIS U.S. LLC | 2 | $66 |
| PFIZER INC. | 4 | $62 |
| Amgen Inc. | 4 | $62 |
| Lilly USA, LLC | 3 | $56 |
| ABBVIE INC. | 3 | $54 |
| Astellas Pharma US Inc | 3 | $47 |
| AstraZeneca Pharmaceuticals LP | 3 | $46 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 2 | $37 |
| Exact Sciences Corporation | 1 | $24 |
Products named: Kerendia, TZIELD, PREVNAR 20, VRAYLAR, Veozah, OTEZLA, MOUNJARO, XIFAXAN.
Industry payments across NJ — which companies pay providers there.
